nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—SLC28A1—Gemcitabine—kidney cancer	0.177	0.298	CbGbCtD
Zidovudine—SLC29A2—Gemcitabine—kidney cancer	0.118	0.198	CbGbCtD
Zidovudine—ABCB1—kidney cancer	0.0968	1	CbGaD
Zidovudine—ABCC4—Sorafenib—kidney cancer	0.0199	0.0335	CbGbCtD
Zidovudine—ABCG2—Pazopanib—kidney cancer	0.0185	0.031	CbGbCtD
Zidovudine—ABCG2—Dactinomycin—kidney cancer	0.0169	0.0284	CbGbCtD
Zidovudine—ABCC4—Sunitinib—kidney cancer	0.0162	0.0271	CbGbCtD
Zidovudine—SLC22A2—Vinblastine—kidney cancer	0.0143	0.0241	CbGbCtD
Zidovudine—ABCG2—Erlotinib—kidney cancer	0.0132	0.0221	CbGbCtD
Zidovudine—ABCB1—Temsirolimus—kidney cancer	0.0127	0.0213	CbGbCtD
Zidovudine—ABCG2—Paclitaxel—kidney cancer	0.0121	0.0203	CbGbCtD
Zidovudine—CYP3A4—Everolimus—kidney cancer	0.0113	0.0189	CbGbCtD
Zidovudine—ABCG2—Sorafenib—kidney cancer	0.0107	0.018	CbGbCtD
Zidovudine—ABCG2—Vincristine—kidney cancer	0.0104	0.0175	CbGbCtD
Zidovudine—CYP2C8—Pazopanib—kidney cancer	0.00984	0.0165	CbGbCtD
Zidovudine—ALB—Erlotinib—kidney cancer	0.00909	0.0153	CbGbCtD
Zidovudine—ABCG2—Sunitinib—kidney cancer	0.00869	0.0146	CbGbCtD
Zidovudine—CYP3A4—Temsirolimus—kidney cancer	0.0076	0.0128	CbGbCtD
Zidovudine—CYP2C9—Capecitabine—kidney cancer	0.00716	0.012	CbGbCtD
Zidovudine—CYP2C8—Erlotinib—kidney cancer	0.00702	0.0118	CbGbCtD
Zidovudine—ABCB1—Pazopanib—kidney cancer	0.00666	0.0112	CbGbCtD
Zidovudine—ABCG2—Doxorubicin—kidney cancer	0.00651	0.0109	CbGbCtD
Zidovudine—CYP2C8—Paclitaxel—kidney cancer	0.00643	0.0108	CbGbCtD
Zidovudine—ABCB1—Dactinomycin—kidney cancer	0.00609	0.0102	CbGbCtD
Zidovudine—CYP2C8—Sorafenib—kidney cancer	0.00571	0.00959	CbGbCtD
Zidovudine—ABCB1—Gemcitabine—kidney cancer	0.00482	0.00809	CbGbCtD
Zidovudine—SLC22A2—nephron—kidney cancer	0.00481	0.0891	CbGeAlD
Zidovudine—CYP2C19—Sorafenib—kidney cancer	0.00479	0.00804	CbGbCtD
Zidovudine—ABCB1—Erlotinib—kidney cancer	0.00475	0.00798	CbGbCtD
Zidovudine—CYP2C9—Paclitaxel—kidney cancer	0.00448	0.00753	CbGbCtD
Zidovudine—ABCB1—Paclitaxel—kidney cancer	0.00435	0.00731	CbGbCtD
Zidovudine—CYP3A4—Pazopanib—kidney cancer	0.00399	0.0067	CbGbCtD
Zidovudine—CYP2C9—Sorafenib—kidney cancer	0.00398	0.00669	CbGbCtD
Zidovudine—ABCB1—Sorafenib—kidney cancer	0.00387	0.00649	CbGbCtD
Zidovudine—ABCB1—Vinblastine—kidney cancer	0.00382	0.00641	CbGbCtD
Zidovudine—ABCB1—Vincristine—kidney cancer	0.00375	0.0063	CbGbCtD
Zidovudine—SLC28A1—nephron tubule—kidney cancer	0.00325	0.0602	CbGeAlD
Zidovudine—ABCB1—Sunitinib—kidney cancer	0.00313	0.00526	CbGbCtD
Zidovudine—SLC22A8—nephron—kidney cancer	0.00312	0.0579	CbGeAlD
Zidovudine—SLC28A1—renal system—kidney cancer	0.00295	0.0547	CbGeAlD
Zidovudine—SLC28A1—kidney—kidney cancer	0.00285	0.0529	CbGeAlD
Zidovudine—CYP3A4—Erlotinib—kidney cancer	0.00285	0.00478	CbGbCtD
Zidovudine—SLC28A1—cortex of kidney—kidney cancer	0.00278	0.0515	CbGeAlD
Zidovudine—CYP3A4—Paclitaxel—kidney cancer	0.00261	0.00438	CbGbCtD
Zidovudine—SLC22A8—urine—kidney cancer	0.0025	0.0464	CbGeAlD
Zidovudine—ABCB1—Doxorubicin—kidney cancer	0.00235	0.00394	CbGbCtD
Zidovudine—CYP3A4—Sorafenib—kidney cancer	0.00232	0.00389	CbGbCtD
Zidovudine—CYP3A4—Vinblastine—kidney cancer	0.00229	0.00384	CbGbCtD
Zidovudine—CYP3A4—Vincristine—kidney cancer	0.00225	0.00377	CbGbCtD
Zidovudine—CYP2C19—urine—kidney cancer	0.0021	0.0389	CbGeAlD
Zidovudine—CYP3A4—Sunitinib—kidney cancer	0.00188	0.00315	CbGbCtD
Zidovudine—CYP2C9—urine—kidney cancer	0.00163	0.0302	CbGeAlD
Zidovudine—SLC29A2—cardiac atrium—kidney cancer	0.00148	0.0274	CbGeAlD
Zidovudine—TK1—Azacitidine—Gemcitabine—kidney cancer	0.00145	1	CbGdCrCtD
Zidovudine—CYP3A4—Doxorubicin—kidney cancer	0.00141	0.00236	CbGbCtD
Zidovudine—CYP3A4—urine—kidney cancer	0.00124	0.023	CbGeAlD
Zidovudine—SLC22A11—nephron tubule—kidney cancer	0.00119	0.0222	CbGeAlD
Zidovudine—SLC22A6—nephron tubule—kidney cancer	0.00113	0.0209	CbGeAlD
Zidovudine—UGT2B7—renal system—kidney cancer	0.00111	0.0207	CbGeAlD
Zidovudine—SLC22A11—renal system—kidney cancer	0.00109	0.0201	CbGeAlD
Zidovudine—UGT2B7—kidney—kidney cancer	0.00108	0.02	CbGeAlD
Zidovudine—SLC22A7—renal system—kidney cancer	0.00106	0.0197	CbGeAlD
Zidovudine—SLC22A11—kidney—kidney cancer	0.00105	0.0195	CbGeAlD
Zidovudine—SLC22A2—nephron tubule—kidney cancer	0.00104	0.0192	CbGeAlD
Zidovudine—SLC22A7—kidney—kidney cancer	0.00102	0.019	CbGeAlD
Zidovudine—SLC22A11—cortex of kidney—kidney cancer	0.00102	0.019	CbGeAlD
Zidovudine—SLC22A7—cortex of kidney—kidney cancer	0.000998	0.0185	CbGeAlD
Zidovudine—ABCC5—nephron tubule—kidney cancer	0.00098	0.0182	CbGeAlD
Zidovudine—SLC22A6—cortex of kidney—kidney cancer	0.000964	0.0179	CbGeAlD
Zidovudine—SLC22A2—renal system—kidney cancer	0.000943	0.0175	CbGeAlD
Zidovudine—SLC22A2—kidney—kidney cancer	0.000912	0.0169	CbGeAlD
Zidovudine—SLC22A2—cortex of kidney—kidney cancer	0.000888	0.0165	CbGeAlD
Zidovudine—ABCC5—cardiac atrium—kidney cancer	0.000798	0.0148	CbGeAlD
Zidovudine—ABCC4—nephron tubule—kidney cancer	0.000679	0.0126	CbGeAlD
Zidovudine—SLC22A8—nephron tubule—kidney cancer	0.000674	0.0125	CbGeAlD
Zidovudine—ABCC4—renal system—kidney cancer	0.000618	0.0114	CbGeAlD
Zidovudine—SLC22A8—renal system—kidney cancer	0.000613	0.0114	CbGeAlD
Zidovudine—ABCC4—kidney—kidney cancer	0.000597	0.0111	CbGeAlD
Zidovudine—SLC22A8—kidney—kidney cancer	0.000592	0.011	CbGeAlD
Zidovudine—ABCC4—cortex of kidney—kidney cancer	0.000581	0.0108	CbGeAlD
Zidovudine—SLC22A8—cortex of kidney—kidney cancer	0.000577	0.0107	CbGeAlD
Zidovudine—ABCG2—nephron tubule—kidney cancer	0.00048	0.00889	CbGeAlD
Zidovudine—CYP2C8—renal system—kidney cancer	0.000448	0.00831	CbGeAlD
Zidovudine—CYP2C8—kidney—kidney cancer	0.000433	0.00804	CbGeAlD
Zidovudine—CYP3A4—renal system—kidney cancer	0.000304	0.00563	CbGeAlD
Zidovudine—CYP3A4—kidney—kidney cancer	0.000294	0.00544	CbGeAlD
Zidovudine—ABCB1—nephron tubule—kidney cancer	0.000236	0.00438	CbGeAlD
Zidovudine—ABCB1—renal system—kidney cancer	0.000215	0.00399	CbGeAlD
Zidovudine—ABCB1—kidney—kidney cancer	0.000208	0.00385	CbGeAlD
Zidovudine—ABCB1—cortex of kidney—kidney cancer	0.000202	0.00375	CbGeAlD
Zidovudine—ABCB1—gonad—kidney cancer	0.000193	0.00357	CbGeAlD
Zidovudine—Dermatitis—Erlotinib—kidney cancer	7.75e-05	0.000455	CcSEcCtD
Zidovudine—Insomnia—Gemcitabine—kidney cancer	7.73e-05	0.000454	CcSEcCtD
Zidovudine—Headache—Erlotinib—kidney cancer	7.71e-05	0.000452	CcSEcCtD
Zidovudine—Loss of consciousness—Paclitaxel—kidney cancer	7.71e-05	0.000452	CcSEcCtD
Zidovudine—Pain—Vincristine—kidney cancer	7.71e-05	0.000452	CcSEcCtD
Zidovudine—Constipation—Vincristine—kidney cancer	7.71e-05	0.000452	CcSEcCtD
Zidovudine—Paraesthesia—Gemcitabine—kidney cancer	7.68e-05	0.00045	CcSEcCtD
Zidovudine—Cardiac disorder—Capecitabine—kidney cancer	7.67e-05	0.00045	CcSEcCtD
Zidovudine—Cough—Paclitaxel—kidney cancer	7.65e-05	0.000449	CcSEcCtD
Zidovudine—Asthenia—Sunitinib—kidney cancer	7.64e-05	0.000448	CcSEcCtD
Zidovudine—Dyspnoea—Gemcitabine—kidney cancer	7.62e-05	0.000447	CcSEcCtD
Zidovudine—Nausea—Vinblastine—kidney cancer	7.61e-05	0.000446	CcSEcCtD
Zidovudine—Somnolence—Gemcitabine—kidney cancer	7.6e-05	0.000446	CcSEcCtD
Zidovudine—Convulsion—Paclitaxel—kidney cancer	7.6e-05	0.000446	CcSEcCtD
Zidovudine—Affect lability—Doxorubicin—kidney cancer	7.58e-05	0.000445	CcSEcCtD
Zidovudine—Nausea—Everolimus—kidney cancer	7.58e-05	0.000444	CcSEcCtD
Zidovudine—Diarrhoea—Sorafenib—kidney cancer	7.58e-05	0.000444	CcSEcCtD
Zidovudine—Pruritus—Sunitinib—kidney cancer	7.54e-05	0.000442	CcSEcCtD
Zidovudine—Chest pain—Paclitaxel—kidney cancer	7.47e-05	0.000438	CcSEcCtD
Zidovudine—Myalgia—Paclitaxel—kidney cancer	7.47e-05	0.000438	CcSEcCtD
Zidovudine—Arthralgia—Paclitaxel—kidney cancer	7.47e-05	0.000438	CcSEcCtD
Zidovudine—Mediastinal disorder—Capecitabine—kidney cancer	7.45e-05	0.000437	CcSEcCtD
Zidovudine—Anxiety—Paclitaxel—kidney cancer	7.44e-05	0.000436	CcSEcCtD
Zidovudine—Decreased appetite—Gemcitabine—kidney cancer	7.43e-05	0.000436	CcSEcCtD
Zidovudine—Chills—Capecitabine—kidney cancer	7.42e-05	0.000435	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	7.42e-05	0.000435	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Gemcitabine—kidney cancer	7.38e-05	0.000433	CcSEcCtD
Zidovudine—Discomfort—Paclitaxel—kidney cancer	7.38e-05	0.000433	CcSEcCtD
Zidovudine—Fatigue—Gemcitabine—kidney cancer	7.37e-05	0.000432	CcSEcCtD
Zidovudine—Gastrointestinal pain—Vincristine—kidney cancer	7.37e-05	0.000432	CcSEcCtD
Zidovudine—Dizziness—Sorafenib—kidney cancer	7.32e-05	0.00043	CcSEcCtD
Zidovudine—Pain—Gemcitabine—kidney cancer	7.31e-05	0.000429	CcSEcCtD
Zidovudine—Constipation—Gemcitabine—kidney cancer	7.31e-05	0.000429	CcSEcCtD
Zidovudine—Nausea—Erlotinib—kidney cancer	7.31e-05	0.000429	CcSEcCtD
Zidovudine—Mood swings—Doxorubicin—kidney cancer	7.3e-05	0.000428	CcSEcCtD
Zidovudine—Diarrhoea—Sunitinib—kidney cancer	7.29e-05	0.000428	CcSEcCtD
Zidovudine—Mental disorder—Capecitabine—kidney cancer	7.24e-05	0.000425	CcSEcCtD
Zidovudine—Asthenia—Dactinomycin—kidney cancer	7.24e-05	0.000425	CcSEcCtD
Zidovudine—Confusional state—Paclitaxel—kidney cancer	7.22e-05	0.000423	CcSEcCtD
Zidovudine—Erythema—Capecitabine—kidney cancer	7.2e-05	0.000422	CcSEcCtD
Zidovudine—Malnutrition—Capecitabine—kidney cancer	7.2e-05	0.000422	CcSEcCtD
Zidovudine—Anaphylactic shock—Paclitaxel—kidney cancer	7.16e-05	0.00042	CcSEcCtD
Zidovudine—Oedema—Paclitaxel—kidney cancer	7.16e-05	0.00042	CcSEcCtD
Zidovudine—Abdominal pain—Vincristine—kidney cancer	7.12e-05	0.000418	CcSEcCtD
Zidovudine—Body temperature increased—Vincristine—kidney cancer	7.12e-05	0.000418	CcSEcCtD
Zidovudine—Flatulence—Capecitabine—kidney cancer	7.09e-05	0.000416	CcSEcCtD
Zidovudine—Dysgeusia—Capecitabine—kidney cancer	7.05e-05	0.000413	CcSEcCtD
Zidovudine—Dizziness—Sunitinib—kidney cancer	7.05e-05	0.000413	CcSEcCtD
Zidovudine—Feeling abnormal—Gemcitabine—kidney cancer	7.05e-05	0.000413	CcSEcCtD
Zidovudine—Shock—Paclitaxel—kidney cancer	7.04e-05	0.000413	CcSEcCtD
Zidovudine—Vomiting—Sorafenib—kidney cancer	7.04e-05	0.000413	CcSEcCtD
Zidovudine—Nervous system disorder—Paclitaxel—kidney cancer	7.02e-05	0.000412	CcSEcCtD
Zidovudine—Thrombocytopenia—Paclitaxel—kidney cancer	7.01e-05	0.000411	CcSEcCtD
Zidovudine—Rash—Sorafenib—kidney cancer	6.98e-05	0.00041	CcSEcCtD
Zidovudine—Dermatitis—Sorafenib—kidney cancer	6.98e-05	0.000409	CcSEcCtD
Zidovudine—Back pain—Capecitabine—kidney cancer	6.96e-05	0.000408	CcSEcCtD
Zidovudine—Breast disorder—Doxorubicin—kidney cancer	6.96e-05	0.000408	CcSEcCtD
Zidovudine—Skin disorder—Paclitaxel—kidney cancer	6.95e-05	0.000408	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	6.94e-05	0.000407	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	6.94e-05	0.000407	CcSEcCtD
Zidovudine—Headache—Sorafenib—kidney cancer	6.94e-05	0.000407	CcSEcCtD
Zidovudine—Muscle spasms—Capecitabine—kidney cancer	6.92e-05	0.000406	CcSEcCtD
Zidovudine—Hyperhidrosis—Paclitaxel—kidney cancer	6.92e-05	0.000406	CcSEcCtD
Zidovudine—Diarrhoea—Dactinomycin—kidney cancer	6.9e-05	0.000405	CcSEcCtD
Zidovudine—Nasopharyngitis—Doxorubicin—kidney cancer	6.89e-05	0.000404	CcSEcCtD
Zidovudine—Anorexia—Paclitaxel—kidney cancer	6.82e-05	0.0004	CcSEcCtD
Zidovudine—Vomiting—Sunitinib—kidney cancer	6.77e-05	0.000397	CcSEcCtD
Zidovudine—Body temperature increased—Gemcitabine—kidney cancer	6.76e-05	0.000396	CcSEcCtD
Zidovudine—Tremor—Capecitabine—kidney cancer	6.74e-05	0.000396	CcSEcCtD
Zidovudine—Rash—Sunitinib—kidney cancer	6.72e-05	0.000394	CcSEcCtD
Zidovudine—Dermatitis—Sunitinib—kidney cancer	6.71e-05	0.000394	CcSEcCtD
Zidovudine—Ill-defined disorder—Capecitabine—kidney cancer	6.68e-05	0.000392	CcSEcCtD
Zidovudine—Headache—Sunitinib—kidney cancer	6.68e-05	0.000392	CcSEcCtD
Zidovudine—Influenza—Doxorubicin—kidney cancer	6.66e-05	0.000391	CcSEcCtD
Zidovudine—Dysphagia—Doxorubicin—kidney cancer	6.66e-05	0.000391	CcSEcCtD
Zidovudine—Anaemia—Capecitabine—kidney cancer	6.65e-05	0.00039	CcSEcCtD
Zidovudine—Nausea—Sorafenib—kidney cancer	6.58e-05	0.000386	CcSEcCtD
Zidovudine—Pancreatitis—Doxorubicin—kidney cancer	6.53e-05	0.000383	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	6.52e-05	0.000383	CcSEcCtD
Zidovudine—Malaise—Capecitabine—kidney cancer	6.49e-05	0.000381	CcSEcCtD
Zidovudine—Insomnia—Paclitaxel—kidney cancer	6.47e-05	0.00038	CcSEcCtD
Zidovudine—Vertigo—Capecitabine—kidney cancer	6.47e-05	0.000379	CcSEcCtD
Zidovudine—Asthenia—Vincristine—kidney cancer	6.47e-05	0.000379	CcSEcCtD
Zidovudine—Syncope—Capecitabine—kidney cancer	6.45e-05	0.000379	CcSEcCtD
Zidovudine—Leukopenia—Capecitabine—kidney cancer	6.44e-05	0.000378	CcSEcCtD
Zidovudine—Paraesthesia—Paclitaxel—kidney cancer	6.43e-05	0.000377	CcSEcCtD
Zidovudine—Vomiting—Dactinomycin—kidney cancer	6.41e-05	0.000376	CcSEcCtD
Zidovudine—Dyspnoea—Paclitaxel—kidney cancer	6.38e-05	0.000374	CcSEcCtD
Zidovudine—Somnolence—Paclitaxel—kidney cancer	6.36e-05	0.000373	CcSEcCtD
Zidovudine—Rash—Dactinomycin—kidney cancer	6.36e-05	0.000373	CcSEcCtD
Zidovudine—Nausea—Sunitinib—kidney cancer	6.33e-05	0.000371	CcSEcCtD
Zidovudine—Loss of consciousness—Capecitabine—kidney cancer	6.33e-05	0.000371	CcSEcCtD
Zidovudine—Pancytopenia—Doxorubicin—kidney cancer	6.32e-05	0.000371	CcSEcCtD
Zidovudine—Dyspepsia—Paclitaxel—kidney cancer	6.3e-05	0.00037	CcSEcCtD
Zidovudine—Cough—Capecitabine—kidney cancer	6.28e-05	0.000368	CcSEcCtD
Zidovudine—Dysuria—Doxorubicin—kidney cancer	6.23e-05	0.000365	CcSEcCtD
Zidovudine—Neutropenia—Doxorubicin—kidney cancer	6.23e-05	0.000365	CcSEcCtD
Zidovudine—Decreased appetite—Paclitaxel—kidney cancer	6.22e-05	0.000365	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.18e-05	0.000362	CcSEcCtD
Zidovudine—Fatigue—Paclitaxel—kidney cancer	6.17e-05	0.000362	CcSEcCtD
Zidovudine—Diarrhoea—Vincristine—kidney cancer	6.17e-05	0.000362	CcSEcCtD
Zidovudine—Pollakiuria—Doxorubicin—kidney cancer	6.15e-05	0.000361	CcSEcCtD
Zidovudine—Asthenia—Gemcitabine—kidney cancer	6.13e-05	0.00036	CcSEcCtD
Zidovudine—Myalgia—Capecitabine—kidney cancer	6.13e-05	0.000359	CcSEcCtD
Zidovudine—Chest pain—Capecitabine—kidney cancer	6.13e-05	0.000359	CcSEcCtD
Zidovudine—Arthralgia—Capecitabine—kidney cancer	6.13e-05	0.000359	CcSEcCtD
Zidovudine—Pain—Paclitaxel—kidney cancer	6.12e-05	0.000359	CcSEcCtD
Zidovudine—Constipation—Paclitaxel—kidney cancer	6.12e-05	0.000359	CcSEcCtD
Zidovudine—Anxiety—Capecitabine—kidney cancer	6.11e-05	0.000358	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	6.09e-05	0.000357	CcSEcCtD
Zidovudine—Discomfort—Capecitabine—kidney cancer	6.05e-05	0.000355	CcSEcCtD
Zidovudine—Pruritus—Gemcitabine—kidney cancer	6.05e-05	0.000355	CcSEcCtD
Zidovudine—Weight decreased—Doxorubicin—kidney cancer	6.02e-05	0.000353	CcSEcCtD
Zidovudine—Nausea—Dactinomycin—kidney cancer	5.99e-05	0.000351	CcSEcCtD
Zidovudine—Dizziness—Vincristine—kidney cancer	5.96e-05	0.00035	CcSEcCtD
Zidovudine—Confusional state—Capecitabine—kidney cancer	5.92e-05	0.000347	CcSEcCtD
Zidovudine—Feeling abnormal—Paclitaxel—kidney cancer	5.9e-05	0.000346	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	5.89e-05	0.000345	CcSEcCtD
Zidovudine—Oedema—Capecitabine—kidney cancer	5.87e-05	0.000345	CcSEcCtD
Zidovudine—Gastrointestinal pain—Paclitaxel—kidney cancer	5.85e-05	0.000343	CcSEcCtD
Zidovudine—Diarrhoea—Gemcitabine—kidney cancer	5.85e-05	0.000343	CcSEcCtD
Zidovudine—Neuropathy peripheral—Doxorubicin—kidney cancer	5.82e-05	0.000341	CcSEcCtD
Zidovudine—Stomatitis—Doxorubicin—kidney cancer	5.79e-05	0.000339	CcSEcCtD
Zidovudine—Jaundice—Doxorubicin—kidney cancer	5.79e-05	0.000339	CcSEcCtD
Zidovudine—Shock—Capecitabine—kidney cancer	5.78e-05	0.000339	CcSEcCtD
Zidovudine—Nervous system disorder—Capecitabine—kidney cancer	5.76e-05	0.000338	CcSEcCtD
Zidovudine—Thrombocytopenia—Capecitabine—kidney cancer	5.75e-05	0.000337	CcSEcCtD
Zidovudine—Vomiting—Vincristine—kidney cancer	5.73e-05	0.000336	CcSEcCtD
Zidovudine—Skin disorder—Capecitabine—kidney cancer	5.71e-05	0.000335	CcSEcCtD
Zidovudine—Sweating—Doxorubicin—kidney cancer	5.69e-05	0.000334	CcSEcCtD
Zidovudine—Urticaria—Paclitaxel—kidney cancer	5.69e-05	0.000334	CcSEcCtD
Zidovudine—Rash—Vincristine—kidney cancer	5.68e-05	0.000333	CcSEcCtD
Zidovudine—Hyperhidrosis—Capecitabine—kidney cancer	5.68e-05	0.000333	CcSEcCtD
Zidovudine—Dermatitis—Vincristine—kidney cancer	5.68e-05	0.000333	CcSEcCtD
Zidovudine—Haematuria—Doxorubicin—kidney cancer	5.66e-05	0.000332	CcSEcCtD
Zidovudine—Abdominal pain—Paclitaxel—kidney cancer	5.66e-05	0.000332	CcSEcCtD
Zidovudine—Body temperature increased—Paclitaxel—kidney cancer	5.66e-05	0.000332	CcSEcCtD
Zidovudine—Headache—Vincristine—kidney cancer	5.65e-05	0.000331	CcSEcCtD
Zidovudine—Hepatobiliary disease—Doxorubicin—kidney cancer	5.61e-05	0.000329	CcSEcCtD
Zidovudine—Epistaxis—Doxorubicin—kidney cancer	5.6e-05	0.000328	CcSEcCtD
Zidovudine—Anorexia—Capecitabine—kidney cancer	5.6e-05	0.000328	CcSEcCtD
Zidovudine—Sinusitis—Doxorubicin—kidney cancer	5.57e-05	0.000327	CcSEcCtD
Zidovudine—Agranulocytosis—Doxorubicin—kidney cancer	5.54e-05	0.000325	CcSEcCtD
Zidovudine—Vomiting—Gemcitabine—kidney cancer	5.44e-05	0.000319	CcSEcCtD
Zidovudine—Rash—Gemcitabine—kidney cancer	5.39e-05	0.000316	CcSEcCtD
Zidovudine—Dermatitis—Gemcitabine—kidney cancer	5.39e-05	0.000316	CcSEcCtD
Zidovudine—Headache—Gemcitabine—kidney cancer	5.36e-05	0.000314	CcSEcCtD
Zidovudine—Nausea—Vincristine—kidney cancer	5.35e-05	0.000314	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.35e-05	0.000314	CcSEcCtD
Zidovudine—Rhinitis—Doxorubicin—kidney cancer	5.34e-05	0.000313	CcSEcCtD
Zidovudine—Hepatitis—Doxorubicin—kidney cancer	5.33e-05	0.000313	CcSEcCtD
Zidovudine—Insomnia—Capecitabine—kidney cancer	5.31e-05	0.000312	CcSEcCtD
Zidovudine—Pharyngitis—Doxorubicin—kidney cancer	5.29e-05	0.00031	CcSEcCtD
Zidovudine—Paraesthesia—Capecitabine—kidney cancer	5.27e-05	0.000309	CcSEcCtD
Zidovudine—Urinary tract disorder—Doxorubicin—kidney cancer	5.26e-05	0.000309	CcSEcCtD
Zidovudine—Connective tissue disorder—Doxorubicin—kidney cancer	5.24e-05	0.000307	CcSEcCtD
Zidovudine—Dyspnoea—Capecitabine—kidney cancer	5.24e-05	0.000307	CcSEcCtD
Zidovudine—Urethral disorder—Doxorubicin—kidney cancer	5.22e-05	0.000306	CcSEcCtD
Zidovudine—Dyspepsia—Capecitabine—kidney cancer	5.17e-05	0.000303	CcSEcCtD
Zidovudine—Asthenia—Paclitaxel—kidney cancer	5.14e-05	0.000301	CcSEcCtD
Zidovudine—Decreased appetite—Capecitabine—kidney cancer	5.11e-05	0.0003	CcSEcCtD
Zidovudine—Nausea—Gemcitabine—kidney cancer	5.08e-05	0.000298	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Capecitabine—kidney cancer	5.07e-05	0.000297	CcSEcCtD
Zidovudine—Fatigue—Capecitabine—kidney cancer	5.06e-05	0.000297	CcSEcCtD
Zidovudine—Pruritus—Paclitaxel—kidney cancer	5.06e-05	0.000297	CcSEcCtD
Zidovudine—Erythema multiforme—Doxorubicin—kidney cancer	5.04e-05	0.000296	CcSEcCtD
Zidovudine—Pain—Capecitabine—kidney cancer	5.02e-05	0.000295	CcSEcCtD
Zidovudine—Constipation—Capecitabine—kidney cancer	5.02e-05	0.000295	CcSEcCtD
Zidovudine—Cardiac disorder—Doxorubicin—kidney cancer	4.95e-05	0.00029	CcSEcCtD
Zidovudine—Diarrhoea—Paclitaxel—kidney cancer	4.9e-05	0.000287	CcSEcCtD
Zidovudine—Feeling abnormal—Capecitabine—kidney cancer	4.84e-05	0.000284	CcSEcCtD
Zidovudine—Gastrointestinal pain—Capecitabine—kidney cancer	4.8e-05	0.000282	CcSEcCtD
Zidovudine—Mediastinal disorder—Doxorubicin—kidney cancer	4.8e-05	0.000282	CcSEcCtD
Zidovudine—Chills—Doxorubicin—kidney cancer	4.78e-05	0.000281	CcSEcCtD
Zidovudine—Dizziness—Paclitaxel—kidney cancer	4.73e-05	0.000278	CcSEcCtD
Zidovudine—Mental disorder—Doxorubicin—kidney cancer	4.67e-05	0.000274	CcSEcCtD
Zidovudine—Urticaria—Capecitabine—kidney cancer	4.67e-05	0.000274	CcSEcCtD
Zidovudine—Abdominal pain—Capecitabine—kidney cancer	4.64e-05	0.000272	CcSEcCtD
Zidovudine—Body temperature increased—Capecitabine—kidney cancer	4.64e-05	0.000272	CcSEcCtD
Zidovudine—Malnutrition—Doxorubicin—kidney cancer	4.64e-05	0.000272	CcSEcCtD
Zidovudine—Erythema—Doxorubicin—kidney cancer	4.64e-05	0.000272	CcSEcCtD
Zidovudine—Flatulence—Doxorubicin—kidney cancer	4.57e-05	0.000268	CcSEcCtD
Zidovudine—Tension—Doxorubicin—kidney cancer	4.55e-05	0.000267	CcSEcCtD
Zidovudine—Vomiting—Paclitaxel—kidney cancer	4.55e-05	0.000267	CcSEcCtD
Zidovudine—Dysgeusia—Doxorubicin—kidney cancer	4.54e-05	0.000267	CcSEcCtD
Zidovudine—Rash—Paclitaxel—kidney cancer	4.51e-05	0.000265	CcSEcCtD
Zidovudine—Dermatitis—Paclitaxel—kidney cancer	4.51e-05	0.000264	CcSEcCtD
Zidovudine—Nervousness—Doxorubicin—kidney cancer	4.51e-05	0.000264	CcSEcCtD
Zidovudine—Back pain—Doxorubicin—kidney cancer	4.49e-05	0.000263	CcSEcCtD
Zidovudine—Headache—Paclitaxel—kidney cancer	4.48e-05	0.000263	CcSEcCtD
Zidovudine—Muscle spasms—Doxorubicin—kidney cancer	4.46e-05	0.000262	CcSEcCtD
Zidovudine—Ill-defined disorder—Doxorubicin—kidney cancer	4.3e-05	0.000253	CcSEcCtD
Zidovudine—Anaemia—Doxorubicin—kidney cancer	4.29e-05	0.000252	CcSEcCtD
Zidovudine—Nausea—Paclitaxel—kidney cancer	4.25e-05	0.000249	CcSEcCtD
Zidovudine—Asthenia—Capecitabine—kidney cancer	4.21e-05	0.000247	CcSEcCtD
Zidovudine—Malaise—Doxorubicin—kidney cancer	4.18e-05	0.000245	CcSEcCtD
Zidovudine—Vertigo—Doxorubicin—kidney cancer	4.17e-05	0.000245	CcSEcCtD
Zidovudine—Syncope—Doxorubicin—kidney cancer	4.16e-05	0.000244	CcSEcCtD
Zidovudine—Pruritus—Capecitabine—kidney cancer	4.16e-05	0.000244	CcSEcCtD
Zidovudine—Leukopenia—Doxorubicin—kidney cancer	4.15e-05	0.000244	CcSEcCtD
Zidovudine—Loss of consciousness—Doxorubicin—kidney cancer	4.08e-05	0.000239	CcSEcCtD
Zidovudine—Cough—Doxorubicin—kidney cancer	4.05e-05	0.000237	CcSEcCtD
Zidovudine—Convulsion—Doxorubicin—kidney cancer	4.02e-05	0.000236	CcSEcCtD
Zidovudine—Diarrhoea—Capecitabine—kidney cancer	4.02e-05	0.000236	CcSEcCtD
Zidovudine—Arthralgia—Doxorubicin—kidney cancer	3.95e-05	0.000232	CcSEcCtD
Zidovudine—Myalgia—Doxorubicin—kidney cancer	3.95e-05	0.000232	CcSEcCtD
Zidovudine—Chest pain—Doxorubicin—kidney cancer	3.95e-05	0.000232	CcSEcCtD
Zidovudine—Anxiety—Doxorubicin—kidney cancer	3.94e-05	0.000231	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.92e-05	0.00023	CcSEcCtD
Zidovudine—Discomfort—Doxorubicin—kidney cancer	3.9e-05	0.000229	CcSEcCtD
Zidovudine—Dizziness—Capecitabine—kidney cancer	3.88e-05	0.000228	CcSEcCtD
Zidovudine—Confusional state—Doxorubicin—kidney cancer	3.82e-05	0.000224	CcSEcCtD
Zidovudine—Oedema—Doxorubicin—kidney cancer	3.79e-05	0.000222	CcSEcCtD
Zidovudine—Anaphylactic shock—Doxorubicin—kidney cancer	3.79e-05	0.000222	CcSEcCtD
Zidovudine—Vomiting—Capecitabine—kidney cancer	3.73e-05	0.000219	CcSEcCtD
Zidovudine—Shock—Doxorubicin—kidney cancer	3.73e-05	0.000219	CcSEcCtD
Zidovudine—Nervous system disorder—Doxorubicin—kidney cancer	3.71e-05	0.000218	CcSEcCtD
Zidovudine—Thrombocytopenia—Doxorubicin—kidney cancer	3.71e-05	0.000217	CcSEcCtD
Zidovudine—Rash—Capecitabine—kidney cancer	3.7e-05	0.000217	CcSEcCtD
Zidovudine—Dermatitis—Capecitabine—kidney cancer	3.7e-05	0.000217	CcSEcCtD
Zidovudine—Headache—Capecitabine—kidney cancer	3.68e-05	0.000216	CcSEcCtD
Zidovudine—Skin disorder—Doxorubicin—kidney cancer	3.68e-05	0.000216	CcSEcCtD
Zidovudine—Hyperhidrosis—Doxorubicin—kidney cancer	3.66e-05	0.000215	CcSEcCtD
Zidovudine—Anorexia—Doxorubicin—kidney cancer	3.61e-05	0.000212	CcSEcCtD
Zidovudine—Nausea—Capecitabine—kidney cancer	3.49e-05	0.000205	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.45e-05	0.000202	CcSEcCtD
Zidovudine—Insomnia—Doxorubicin—kidney cancer	3.42e-05	0.000201	CcSEcCtD
Zidovudine—Paraesthesia—Doxorubicin—kidney cancer	3.4e-05	0.000199	CcSEcCtD
Zidovudine—Dyspnoea—Doxorubicin—kidney cancer	3.38e-05	0.000198	CcSEcCtD
Zidovudine—Somnolence—Doxorubicin—kidney cancer	3.37e-05	0.000197	CcSEcCtD
Zidovudine—Dyspepsia—Doxorubicin—kidney cancer	3.33e-05	0.000196	CcSEcCtD
Zidovudine—Decreased appetite—Doxorubicin—kidney cancer	3.29e-05	0.000193	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.27e-05	0.000192	CcSEcCtD
Zidovudine—Fatigue—Doxorubicin—kidney cancer	3.26e-05	0.000191	CcSEcCtD
Zidovudine—Pain—Doxorubicin—kidney cancer	3.24e-05	0.00019	CcSEcCtD
Zidovudine—Constipation—Doxorubicin—kidney cancer	3.24e-05	0.00019	CcSEcCtD
Zidovudine—Feeling abnormal—Doxorubicin—kidney cancer	3.12e-05	0.000183	CcSEcCtD
Zidovudine—Gastrointestinal pain—Doxorubicin—kidney cancer	3.1e-05	0.000182	CcSEcCtD
Zidovudine—Urticaria—Doxorubicin—kidney cancer	3.01e-05	0.000176	CcSEcCtD
Zidovudine—Abdominal pain—Doxorubicin—kidney cancer	2.99e-05	0.000176	CcSEcCtD
Zidovudine—Body temperature increased—Doxorubicin—kidney cancer	2.99e-05	0.000176	CcSEcCtD
Zidovudine—Asthenia—Doxorubicin—kidney cancer	2.72e-05	0.000159	CcSEcCtD
Zidovudine—Pruritus—Doxorubicin—kidney cancer	2.68e-05	0.000157	CcSEcCtD
Zidovudine—Diarrhoea—Doxorubicin—kidney cancer	2.59e-05	0.000152	CcSEcCtD
Zidovudine—Dizziness—Doxorubicin—kidney cancer	2.5e-05	0.000147	CcSEcCtD
Zidovudine—Vomiting—Doxorubicin—kidney cancer	2.41e-05	0.000141	CcSEcCtD
Zidovudine—Rash—Doxorubicin—kidney cancer	2.39e-05	0.00014	CcSEcCtD
Zidovudine—Dermatitis—Doxorubicin—kidney cancer	2.39e-05	0.00014	CcSEcCtD
Zidovudine—Headache—Doxorubicin—kidney cancer	2.37e-05	0.000139	CcSEcCtD
Zidovudine—Nausea—Doxorubicin—kidney cancer	2.25e-05	0.000132	CcSEcCtD
Zidovudine—CYP2C19—Metabolism—SLC5A3—kidney cancer	8.76e-06	0.000107	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PGK1—kidney cancer	8.76e-06	0.000107	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ALAD—kidney cancer	8.74e-06	0.000107	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—MAPK3—kidney cancer	8.73e-06	0.000107	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—KRAS—kidney cancer	8.71e-06	0.000107	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—LDHB—kidney cancer	8.59e-06	0.000105	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—POMC—kidney cancer	8.59e-06	0.000105	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PGK1—kidney cancer	8.55e-06	0.000105	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—SLC5A3—kidney cancer	8.55e-06	0.000105	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PDHB—kidney cancer	8.53e-06	0.000104	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ST3GAL2—kidney cancer	8.53e-06	0.000104	CbGpPWpGaD
Zidovudine—CYP3A4—Biological oxidations—POMC—kidney cancer	8.5e-06	0.000104	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CYP1A1—kidney cancer	8.49e-06	0.000104	CbGpPWpGaD
Zidovudine—ABCC5—Disease—RAF1—kidney cancer	8.45e-06	0.000104	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—BCHE—kidney cancer	8.45e-06	0.000103	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—LDHB—kidney cancer	8.39e-06	0.000103	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	8.38e-06	0.000103	CbGpPWpGaD
Zidovudine—ABCC5—Disease—ERBB2—kidney cancer	8.36e-06	0.000102	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—BCHE—kidney cancer	8.36e-06	0.000102	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CA9—kidney cancer	8.35e-06	0.000102	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—SLC5A5—kidney cancer	8.34e-06	0.000102	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—SCARB1—kidney cancer	8.34e-06	0.000102	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ALDH1A1—kidney cancer	8.33e-06	0.000102	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—MAPK1—kidney cancer	8.3e-06	0.000102	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CA9—kidney cancer	8.3e-06	0.000102	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—SLC5A5—kidney cancer	8.26e-06	0.000101	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MTOR—kidney cancer	8.25e-06	0.000101	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTGS1—kidney cancer	8.25e-06	0.000101	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CD4—kidney cancer	8.24e-06	0.000101	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTGS2—kidney cancer	8.18e-06	0.0001	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.16e-06	9.99e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.11e-06	9.93e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	8.1e-06	9.91e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PSMD7—kidney cancer	8.09e-06	9.91e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—SLC2A1—kidney cancer	8.06e-06	9.87e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CCBL1—kidney cancer	8.02e-06	9.82e-05	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PIK3CA—kidney cancer	8e-06	9.8e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PGK1—kidney cancer	7.99e-06	9.78e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SLC5A3—kidney cancer	7.99e-06	9.78e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—SLC2A1—kidney cancer	7.97e-06	9.76e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	7.97e-06	9.76e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—KRAS—kidney cancer	7.84e-06	9.6e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—LDHB—kidney cancer	7.83e-06	9.59e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CDKN1B—kidney cancer	7.75e-06	9.48e-05	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—kidney cancer	7.74e-06	9.48e-05	CbGpPWpGaD
Zidovudine—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	7.68e-06	9.41e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—BCHE—kidney cancer	7.67e-06	9.4e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	7.66e-06	9.38e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	7.6e-06	9.31e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—SLC5A5—kidney cancer	7.58e-06	9.28e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	7.54e-06	9.23e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CA9—kidney cancer	7.45e-06	9.12e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	7.34e-06	8.98e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—SLC2A1—kidney cancer	7.32e-06	8.96e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CTNNB1—kidney cancer	7.32e-06	8.96e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	7.29e-06	8.92e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.28e-06	8.92e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CA9—kidney cancer	7.27e-06	8.9e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—PIK3CA—kidney cancer	7.2e-06	8.82e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	7.18e-06	8.79e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTEN—kidney cancer	7.13e-06	8.73e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CRABP1—kidney cancer	7.1e-06	8.69e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CRABP1—kidney cancer	7.06e-06	8.64e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—kidney cancer	6.97e-06	8.53e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GLIPR1—kidney cancer	6.95e-06	8.51e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PPAT—kidney cancer	6.95e-06	8.51e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTGS2—kidney cancer	6.85e-06	8.39e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CA9—kidney cancer	6.79e-06	8.32e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	6.78e-06	8.3e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GSTP1—kidney cancer	6.72e-06	8.23e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GSTP1—kidney cancer	6.65e-06	8.14e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.64e-06	8.13e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ITPR2—kidney cancer	6.6e-06	8.08e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ITPR2—kidney cancer	6.56e-06	8.03e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—FH—kidney cancer	6.46e-06	7.91e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—APRT—kidney cancer	6.46e-06	7.91e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ABCB1—kidney cancer	6.36e-06	7.79e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CRABP1—kidney cancer	6.33e-06	7.76e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—POMC—kidney cancer	6.33e-06	7.75e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	6.32e-06	7.74e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ABCB1—kidney cancer	6.3e-06	7.71e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.23e-06	7.62e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CRABP1—kidney cancer	6.18e-06	7.57e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GSTM1—kidney cancer	6.18e-06	7.56e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GSTM1—kidney cancer	6.11e-06	7.48e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSTP1—kidney cancer	6.11e-06	7.48e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MAPK3—kidney cancer	6.09e-06	7.46e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.08e-06	7.45e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GPC3—kidney cancer	6.08e-06	7.44e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.05e-06	7.41e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6.02e-06	7.38e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTT1—kidney cancer	6.02e-06	7.37e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ACHE—kidney cancer	6.02e-06	7.37e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTT1—kidney cancer	5.98e-06	7.33e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ACHE—kidney cancer	5.98e-06	7.33e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTEN—kidney cancer	5.97e-06	7.31e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MYC—kidney cancer	5.93e-06	7.26e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CA2—kidney cancer	5.91e-06	7.24e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ITPR2—kidney cancer	5.89e-06	7.21e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CYP1A1—kidney cancer	5.85e-06	7.17e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MAPK1—kidney cancer	5.8e-06	7.1e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CYP1A1—kidney cancer	5.79e-06	7.09e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ABCB1—kidney cancer	5.78e-06	7.08e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CRABP1—kidney cancer	5.78e-06	7.07e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ALAD—kidney cancer	5.76e-06	7.05e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ITPR2—kidney cancer	5.75e-06	7.04e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—SCARB1—kidney cancer	5.7e-06	6.97e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—SCARB1—kidney cancer	5.66e-06	6.93e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS1—kidney cancer	5.64e-06	6.9e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	5.62e-06	6.88e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GSTM1—kidney cancer	5.61e-06	6.87e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS1—kidney cancer	5.61e-06	6.86e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PSMD7—kidney cancer	5.53e-06	6.77e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PSMD7—kidney cancer	5.5e-06	6.73e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.5e-06	6.73e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—RAF1—kidney cancer	5.48e-06	6.71e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—KRAS—kidney cancer	5.48e-06	6.71e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.43e-06	6.65e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ACHE—kidney cancer	5.37e-06	6.58e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTT1—kidney cancer	5.37e-06	6.58e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ITPR2—kidney cancer	5.37e-06	6.58e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CYP1A1—kidney cancer	5.32e-06	6.51e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PGK1—kidney cancer	5.27e-06	6.45e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.27e-06	6.45e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ACHE—kidney cancer	5.24e-06	6.42e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTT1—kidney cancer	5.24e-06	6.42e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—BCHE—kidney cancer	5.24e-06	6.42e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—BCHE—kidney cancer	5.21e-06	6.38e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—SLC5A5—kidney cancer	5.18e-06	6.34e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—LDHB—kidney cancer	5.17e-06	6.33e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—SLC5A5—kidney cancer	5.15e-06	6.3e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—SCARB1—kidney cancer	5.08e-06	6.22e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTGS2—kidney cancer	5.05e-06	6.18e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS1—kidney cancer	5.03e-06	6.16e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PIK3CA—kidney cancer	5.03e-06	6.16e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—SLC2A1—kidney cancer	5e-06	6.12e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—SLC2A1—kidney cancer	4.97e-06	6.09e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—SCARB1—kidney cancer	4.96e-06	6.08e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.95e-06	6.06e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PSMD7—kidney cancer	4.94e-06	6.04e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS1—kidney cancer	4.91e-06	6.01e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—IL2—kidney cancer	4.91e-06	6.01e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTT1—kidney cancer	4.9e-06	6e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ACHE—kidney cancer	4.9e-06	6e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.85e-06	5.94e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.82e-06	5.91e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PSMD7—kidney cancer	4.82e-06	5.9e-05	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	4.74e-06	5.81e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—BCHE—kidney cancer	4.68e-06	5.73e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SCARB1—kidney cancer	4.64e-06	5.68e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—SLC5A5—kidney cancer	4.62e-06	5.66e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS1—kidney cancer	4.59e-06	5.62e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—BCHE—kidney cancer	4.57e-06	5.59e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—SLC5A5—kidney cancer	4.51e-06	5.52e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PSMD7—kidney cancer	4.5e-06	5.51e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CA9—kidney cancer	4.48e-06	5.49e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—SLC2A1—kidney cancer	4.46e-06	5.46e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTEN—kidney cancer	4.4e-06	5.39e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—POMC—kidney cancer	4.36e-06	5.34e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—SLC2A1—kidney cancer	4.36e-06	5.33e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.33e-06	5.3e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—POMC—kidney cancer	4.32e-06	5.29e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—BCHE—kidney cancer	4.27e-06	5.22e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.23e-06	5.18e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PIK3CA—kidney cancer	4.21e-06	5.16e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SLC5A5—kidney cancer	4.21e-06	5.16e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.21e-06	5.15e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—VEGFA—kidney cancer	4.17e-06	5.11e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTP1—kidney cancer	4.17e-06	5.11e-05	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.15e-06	5.09e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTP1—kidney cancer	4.15e-06	5.08e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.07e-06	4.98e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—POMC—kidney cancer	3.97e-06	4.86e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.95e-06	4.83e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—MAPK3—kidney cancer	3.95e-06	4.83e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ABCB1—kidney cancer	3.95e-06	4.83e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ABCB1—kidney cancer	3.93e-06	4.81e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTM1—kidney cancer	3.83e-06	4.69e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTM1—kidney cancer	3.81e-06	4.67e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CRABP1—kidney cancer	3.81e-06	4.66e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.78e-06	4.62e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—MAPK1—kidney cancer	3.76e-06	4.6e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTP1—kidney cancer	3.72e-06	4.56e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTP1—kidney cancer	3.63e-06	4.45e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP1A1—kidney cancer	3.63e-06	4.45e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP1A1—kidney cancer	3.61e-06	4.42e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—KRAS—kidney cancer	3.55e-06	4.34e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ITPR2—kidney cancer	3.54e-06	4.34e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ABCB1—kidney cancer	3.52e-06	4.31e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTGS2—kidney cancer	3.48e-06	4.26e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTGS2—kidney cancer	3.45e-06	4.22e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.44e-06	4.22e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTM1—kidney cancer	3.42e-06	4.19e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTP1—kidney cancer	3.39e-06	4.16e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTM1—kidney cancer	3.34e-06	4.09e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CA—kidney cancer	3.26e-06	3.99e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.24e-06	3.97e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ACHE—kidney cancer	3.23e-06	3.95e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTT1—kidney cancer	3.23e-06	3.95e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ABCB1—kidney cancer	3.21e-06	3.93e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP1A1—kidney cancer	3.17e-06	3.88e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTGS2—kidney cancer	3.16e-06	3.87e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—kidney cancer	3.15e-06	3.86e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTM1—kidney cancer	3.12e-06	3.82e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CA—kidney cancer	3.11e-06	3.8e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SCARB1—kidney cancer	3.06e-06	3.74e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTEN—kidney cancer	3.04e-06	3.72e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS1—kidney cancer	3.03e-06	3.71e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTEN—kidney cancer	3e-06	3.68e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.98e-06	3.65e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.97e-06	3.63e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PSMD7—kidney cancer	2.97e-06	3.63e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.96e-06	3.62e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—BCHE—kidney cancer	2.81e-06	3.44e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.78e-06	3.4e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTEN—kidney cancer	2.76e-06	3.38e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—POMC—kidney cancer	2.71e-06	3.32e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—POMC—kidney cancer	2.69e-06	3.3e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.68e-06	3.29e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.66e-06	3.26e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.43e-06	2.97e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—POMC—kidney cancer	2.42e-06	2.96e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—POMC—kidney cancer	2.36e-06	2.89e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTP1—kidney cancer	2.24e-06	2.74e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—POMC—kidney cancer	2.2e-06	2.7e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS2—kidney cancer	2.16e-06	2.65e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS2—kidney cancer	2.15e-06	2.63e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CA—kidney cancer	2.14e-06	2.62e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CA—kidney cancer	2.12e-06	2.6e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ABCB1—kidney cancer	2.12e-06	2.59e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTM1—kidney cancer	2.06e-06	2.52e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.95e-06	2.39e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CA—kidney cancer	1.95e-06	2.38e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS2—kidney cancer	1.93e-06	2.36e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTEN—kidney cancer	1.88e-06	2.31e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS2—kidney cancer	1.88e-06	2.3e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTEN—kidney cancer	1.87e-06	2.29e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS2—kidney cancer	1.76e-06	2.15e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTEN—kidney cancer	1.68e-06	2.06e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTEN—kidney cancer	1.64e-06	2.01e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTEN—kidney cancer	1.53e-06	1.88e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—POMC—kidney cancer	1.45e-06	1.78e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.33e-06	1.63e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CA—kidney cancer	1.32e-06	1.62e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.19e-06	1.45e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.16e-06	1.42e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.16e-06	1.42e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.08e-06	1.32e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTEN—kidney cancer	1.01e-06	1.24e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.13e-07	8.74e-06	CbGpPWpGaD
